Dimensional Fund Advisors LP Avrobio, Inc. Transaction History

Dimensional Fund Advisors LP

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$0.75 - $1.33 $15,631 - $27,719	-20,842 Closed	0 $0
Q1 2022 May 13, 2022	SELL	$1.29 - $4.04 $32,462 - $101,666	-25,165 Reduced 54.7%	20,842 $28,000
Q4 2021 Feb 09, 2022	BUY	$3.45 - $6.05 $26,892 - $47,159	7,795 Added 20.4%	46,007 $177,000
Q3 2021 Nov 12, 2021	SELL	$5.53 - $9.28 $66,304 - $111,267	-11,990 Reduced 23.88%	38,212 $213,000
Q2 2021 Aug 12, 2021	SELL	$7.84 - $12.6 $29,376 - $47,212	-3,747 Reduced 6.95%	50,202 $446,000
Q1 2021 May 14, 2021	BUY	$10.54 - $19.3 $81,189 - $148,667	7,703 Added 16.66%	53,949 $685,000
Q4 2020 Feb 25, 2021	BUY	$12.79 - $17.1 $591,486 - $790,806	46,246 New	46,246 $645,000

559K

Ticker AVRO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 43,773,900
Description
AVROBIO, Inc., a clinical-stage gene therapy company, develops ex vivo lentiviral-based gene therapies to treat rare diseases following a single dose worldwide. Its gene therapies employ hematopoietic stem cells that are collected from patients and modified with a lentiviral vector to insert functional copies of the gene that is defective in the...

Get notified when there are updates to the investment portfolio of Dimensional Fund Advisors LP, based on Form 13F filings with the SEC.

Stay updated on Dimensional Fund Advisors LP with notifications on news.